CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- 8-K Event Material agreement · Other events
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K/A Event Exhibits
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 9 of 68 · 1,360 filings